Paul Calabresi

3.8k citations
105 papers · 3.1k indexed · 1 hit paper · h-index 31
Topics
Biochemical and Molecular Research (15 papers)Colorectal Cancer Treatments and Studies (10 papers)Cancer Treatment and Pharmacology (9 papers)

In The Last Decade

Paul Calabresi

102 papers receiving 2.8k citations

Hit Papers

N,N-dimethylformamide-induced alteration of cell culture ...1979202619942010197950100150200

Peers

Paul Calabresi
Comparison fields: 5 of 120
  • Molecular Biology 1.3k
  • Oncology 885
  • Cancer Research 489
  • Pulmonary and Respiratory Medicine 445
  • Immunology 390
Replace E.H. Cooper with:
E.H. Cooper United Kingdom
Irwin H. Krakoff United States
Samuel O. Freedman Canada
Susan L. Kelley United States
S. E. Salmon United States
Joseph H. Burchenal United States
F. M. Schabel United States
Benjamin Drewinko United States
Sepp Leodolter Austria
Curt Peterson Sweden
Paul Calabresi relative to E.H. Cooper United Kingdom E.H. Cooper's profile →
Citations per field
00.5×
E.H. Cooper · 1×
Citations per year

Countries citing papers authored by Paul Calabresi

Since Specialization
Citations

This map shows the geographic impact of Paul Calabresi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Calabresi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Calabresi more than expected).

Fields of papers citing papers by Paul Calabresi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Calabresi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Calabresi. The network helps show where Paul Calabresi may publish in the future.

Co-authorship network of co-authors of Paul Calabresi

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Calabresi. A scholar is included among the top collaborators of Paul Calabresi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Calabresi. Paul Calabresi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 25
2 20
3 6
4 5
5 7
6 10
7 124
8 9
9 14
10 35
11 4
12 16
13
Basic principles and clinical management of cancer
7
14 7
15 1
16 29
17
Clinical and pharmacological studies with 2',3',5'-triacetyl-6-azauridine.
57
18
CURRENT STATUS OF CLINICAL INVESTIGATIONS WITH 6-AZAURIDINE, 5-IODO-2'-DEOXYURIDINE, AND RELATED DERIVATIVES.
44
19
Pharmacological and clinical studies with triacetyl 6-azauridine.
6
20 52

About Paul Calabresi

Paul Calabresi is a scholar working on Cancer Research, Oncology and Physiology, having authored 105 papers that have together received 3.1k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (15 papers), Colorectal Cancer Treatments and Studies (10 papers) and Cancer Treatment and Pharmacology (9 papers). The work is most often cited by research in Cancer Research (489 citations), Oncology (885 citations) and Molecular Biology (1.3k citations). Paul Calabresi has collaborated with scholars based in United States, South Korea and Ireland. Frequent co-authors include Daniel L. Dexter, J A Barbosa, Charles J. McDonald, Walter H. Abelmann, Stephen R. Kaplan, Ronald C. DeConti, William A. Creasey, Arnold D. Welch, Gloria H. Heppner and James W. Darnowski. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026